Doi T[Author] - Search Results

Year	Number of Results
1954	1
1964	2
1965	3
1966	1
1967	7
1968	2
1969	13
1970	11
1971	6
1972	10
1973	2
1974	6
1975	8
1976	4
1977	5
1978	7
1979	5
1980	5
1981	5
1982	10
1983	13
1984	13
1985	12
1986	15
1987	19
1988	8
1989	25
1990	23
1991	18
1992	26
1993	38
1994	19
1995	26
1996	28
1997	38
1998	36
1999	39
2000	32
2001	46
2002	50
2003	37
2004	40
2005	61
2006	57
2007	84
2008	61
2009	83
2010	98
2011	108
2012	92
2013	106
2014	106
2015	139
2016	126
2017	129
2018	126
2019	125
2020	123
2021	165
2022	133
2023	123
2024	58

1

LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinoma.

Sun JM, Adenis A, C Enzinger P, Shah MA, Kato K, Bennouna J, Doi T, Hawk NN, Yu L, Shah S, Bhagia P, Shen L. Sun JM, et al. Among authors: doi t. Future Oncol. 2024 May 2. doi: 10.2217/fon-2022-1148. Online ahead of print. Future Oncol. 2024. PMID: 38695479 Review.

2

Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial.

Doi T, Langsted A, Nordestgaard BG. Doi T, et al. Atherosclerosis. 2024 Apr 20;393:117556. doi: 10.1016/j.atherosclerosis.2024.117556. Online ahead of print. Atherosclerosis. 2024. PMID: 38678642 Free article.

3

PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study.

Kuboki Y, Koyama T, Matsubara N, Naito Y, Kondo S, Harano K, Yonemori K, Yoh K, Gu Y, Mita T, Chen X, Ueda E, Yamamoto N, Doi T, Shimizu T. Kuboki Y, et al. Among authors: doi t. Cancer Med. 2024 Apr;13(8):e6980. doi: 10.1002/cam4.6980. Cancer Med. 2024. PMID: 38651187 Free PMC article. Clinical Trial.

4

Japan-Multimodal Intervention Trial for the Prevention of Dementia: A randomized controlled trial.

Sakurai T, Sugimoto T, Akatsu H, Doi T, Fujiwara Y, Hirakawa A, Kinoshita F, Kuzuya M, Lee S, Matsumoto N, Matsuo K, Michikawa M, Nakamura A, Ogawa S, Otsuka R, Sato K, Shimada H, Suzuki H, Suzuki H, Takechi H, Takeda S, Uchida K, Umegaki H, Wakayama S, Arai H; J‐MINT study group. Sakurai T, et al. Among authors: doi t. Alzheimers Dement. 2024 Apr 22. doi: 10.1002/alz.13838. Online ahead of print. Alzheimers Dement. 2024. PMID: 38646854

5

Current status of preoperative endoscopic biliary drainage for distal and hilar biliary obstruction.

Ishiwatari H, Sato J, Sakamoto H, Doi T, Ono H. Ishiwatari H, et al. Among authors: doi t. Dig Endosc. 2024 Apr 17. doi: 10.1111/den.14786. Online ahead of print. Dig Endosc. 2024. PMID: 38629308 Review.

6

Combined Social Frailty and Life-Space Activities Associated with Risk of Disability: A Prospective Cohort Study.

Doi T, Tsutsumimoto K, Makino K, Nakakubo S, Sakimoto F, Matsuda S, Shimada H. Doi T, et al. J Frailty Aging. 2024;13(2):184-188. doi: 10.14283/jfa.2024.17. J Frailty Aging. 2024. PMID: 38616376

7

Impact of Albumin Leakage on the Mortality of Patients Receiving Hemodialysis or Online Hemodiafiltration.

Tashiro M, Okada K, Tanaka Y, Michiwaki H, Shima H, Inoue T, Doi T, Minakuchi J. Tashiro M, et al. Among authors: doi t. J Clin Med. 2024 Mar 24;13(7):1865. doi: 10.3390/jcm13071865. J Clin Med. 2024. PMID: 38610630 Free PMC article.

8

First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study.

Kato K, Kojima T, Hara H, Tsuji A, Yasui H, Muro K, Satoh T, Ogata T, Ishihara R, Goto M, Baba H, Nishina T, Han S, Iwakami K, Yatsuzuka N, Doi T. Kato K, et al. Among authors: doi t. Esophagus. 2024 Apr 12. doi: 10.1007/s10388-024-01053-z. Online ahead of print. Esophagus. 2024. PMID: 38607538

9

New Dihydropyridine Derivative Attenuates NF-κB Activation via Suppression of Calcium Influx in a Mouse BV-2 Microglial Cell Line.

Sato K, Sasaki Y, Ohno-Oishi M, Kano K, Aoki J, Ohsawa K, Doi T, Yamakoshi H, Iwabuchi Y, Kawano C, Hirata Y, Nakazawa T. Sato K, et al. Among authors: doi t. Tohoku J Exp Med. 2024 Apr 4. doi: 10.1620/tjem.2024.J024. Online ahead of print. Tohoku J Exp Med. 2024. PMID: 38569887 Free article. No abstract available.

10

Impact of Hemoglobin Level, White Blood Cell Count, Renal Dysfunction, and Staphylococcus as the Causative Organism on Prediction of In-Hospital Mortality from Infective Endocarditis.

Koike M, Doi T, Morishita K, Uruno K, Kawasaki-Nabuchi M, Komuro K, Iwano H, Naraoka S, Nagahara D, Yuda S. Koike M, et al. Among authors: doi t. Int Heart J. 2024;65(2):199-210. doi: 10.1536/ihj.23-360. Int Heart J. 2024. PMID: 38556331 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

2,533 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

2,533 results

Results by year